About AVITA Medical, Inc. 
AVITA Medical, Inc.
Pharmaceuticals & Biotechnology
AVITA Medical Inc., formerly AVITA Therapeutics, Inc., is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. Its technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. It has developed RECELL System, a product for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. It can be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury.
Company Coordinates 
Company Details
28159 Avenue Stanford, Suite 220 , VALENCIA CA : 91355
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 35 Schemes (15.63%)
Foreign Institutions
Held by 25 Foreign Institutions (2.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Lou Panaccio
Independent Non-Executive Chairman of the board
Dr. Michael Perry
Chief Executive Officer, Executive Director
Mr. Jeremy Cook
Independent Non-Executive Director
Prof. Suzanne Crowe
Independent Non-Executive Director
Mr. Louis Drapeau
Independent Non-Executive Director
Revenue and Profits:
Net Sales:
18 Million
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
Pharmaceuticals & Biotechnology
USD 112 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-2.06
400.04%
-8.69






